Chronic intestinal pseudo-obstruction : associations with gut microbiota and genes expression of intestinal serotonergic pathway

© 2024. The Author(s)..

BACKGROUND: Pediatric chronic intestinal pseudo-obstruction (PIPO) is a rare disease characterized by symptoms and radiological signs suggestive of intestinal obstruction, in the absence of lumen-occluding lesions. It results from an extremely severe impairment of propulsive motility. The intestinal endocrine system (IES) jointly with the enteric nervous system (ENS) regulates secreto-motor functions via different hormones and bioactive messengers/neurotransmitters. The neurotransmitter 5-hydroxytryptamine (5-HT) (or serotonin) is linked to intestinal peristalsis and secretory reflexes. Gut microbiota and its interplay with ENS affect 5-HT synthesis, release, and the subsequent serotonin receptor activation. To date, the interplay between 5-HT and gut microbiota in PIPO remains largely unclear. This study aimed to assess correlations between mucosa associated microbiota (MAM), intestinal serotonin-related genes expression in PIPO. To this purpose, biopsies of the colon, ileum and duodenum have been collected from 7 PIPO patients, and 7 age-/sex-matched healthy controls. After DNA extraction, the MAM was assessed by next generation sequencing (NGS) of the V3-V4 region of the bacterial RNA 16 S, on an Illumina Miseq platform. The expression of genes implicated in serotoninergic pathway (TPH1, SLC6A4, 5-HTR3 and 5-HTR4) was established by qPCR, and correlations with MAM and clinical parameters of PIPO have been evaluated.

RESULTS: Our results revealed that PIPO patients exhibit a MAM with a different composition and with dysbiosis, i.e. with a lower biodiversity and fewer less connected species with a greater number of non-synergistic relationships, compared to controls. qPCR results revealed modifications in the expression of serotonin-related intestinal genes in PIPO patients, when compared to controls. Correlation analysis do not reveal any kind of connection.

CONCLUSIONS: For the first time, we report in PIPO patients a specific MAM associated to underlying pathology and an altered intestinal serotonin pathway. A possible dysfunction of the serotonin pathway, possibly related to or triggered by an altered microbiota, may contribute to dysmotility in PIPO patients. The results of our pilot study provide the basis for new biomarkers and innovative therapies targeting the microbiota or serotonin pathways in PIPO patients.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:24

Enthalten in:

BMC microbiology - 24(2024), 1 vom: 02. Feb., Seite 48

Sprache:

Englisch

Beteiligte Personen:

Radocchia, Giulia [VerfasserIn]
Marazzato, Massimiliano [VerfasserIn]
Harbi, Karim Ben [VerfasserIn]
Capuzzo, Elena [VerfasserIn]
Pantanella, Fabrizio [VerfasserIn]
De Giorgio, Roberto [VerfasserIn]
Guarino, Matteo [VerfasserIn]
Costanzini, Anna [VerfasserIn]
Zenzeri, Letizia [VerfasserIn]
Parisi, Pasquale [VerfasserIn]
Ferretti, Alessandro [VerfasserIn]
Felici, Enrico [VerfasserIn]
Palamara, Anna Teresa [VerfasserIn]
Di Nardo, Giovanni [VerfasserIn]
Schippa, Serena [VerfasserIn]

Links:

Volltext

Themen:

333DO1RDJY
Chronic intestinal pseudo-obstruction (CIPO)
Dysbiosis
Gut microbiota
Journal Article
Peristalsis
SLC6A4 protein, human
Serotonin
Serotonin Plasma Membrane Transport Proteins
Serotonin pathway

Anmerkungen:

Date Completed 05.02.2024

Date Revised 05.02.2024

published: Electronic

Citation Status MEDLINE

doi:

10.1186/s12866-024-03200-z

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM367922355